Clinical validation of the Lumipulse G β‐amyloid ratio (1‐42/1‐40) in a subset of ADNI CSF samples von Esquivel, Rianne N., Benina, Natalya, Hawkins, Douglas M., De Simone, Francesca, Le Bastard, Nathalie, Vandijck, Manu, Gannon, Sara, Latham, Jessica, Radwan, Rachel R., Dickson, Diana

Volltext

Using cerebrospinal fluid amyloid‐beta (1‐42) in the memory clinic: Concordance with PET and use of biomarker ratios across immunoassays: Biomarkers (non‐neuroimaging): Method deve... von Willemse, Eline A.J., Tijms, Betty M., Van Berckel, Bart N.M., Gannon, Sara, Le Bastard, Nathalie, Latham, Jessica, Radwan, Rachel R., van Der Flier, Wiesje, Scheltens, Philip, Teunissen, Charlotte E.

Volltext

Prediction of amyloid PET status using the LUMIPULSE G β‐amyloid ratio (1‐42/1‐40) von Willemse, Eline A.J., Tijms, Betty M., Van Berckel, Bart N.M., van Der Flier, Wiesje, Gannon, Sara, Bastard, Nathalie Le, Radwan, Rachel R., Esquivel, Rianne N., Latham, Jessica, Benina, Natalya, Dickson, Diana, Scheltens, Philip, Teunissen, Charlotte E.

Volltext

Using cerebrospinal fluid amyloid‐beta(1‐42) in the memory clinic: Concordance with PET and use of biomarker ratios across immunoassays von Willemse, Eline A.J., Tijms, Betty M., Van Berckel, Bart N.M., Gannon, Sara, Le Bastard, Nathalie, Latham, Jessica, Radwan, Rachel R., van Der Flier, Wiesje, Scheltens, Philip, Teunissen, Charlotte E.

Volltext

Abstract 5299: Monitoring of ovarian cancer recurrence and progression via Lumipulse G CA125II assay von Radwan, Rachel R., Raju, Savitha S., Gannon, Sara J., Le, John, Jones, Sharee D., Peacock, Catherine, Falcone, Katherine, Young, Julianna T., Li, Zhong-Qian, Dickson, Diana L.

Volltext

Comparison of serum CYFRA 21-1 and ROMA in distinguishing ovarian cancer from benign pelvic masses von Li, Zhong-Qian, Smalley, Robert J, Glover, Curtis L, Raju, Savitha, Falcone, Katherine, Fegely, Maryellen, He, Kuanglin, Radwan, Rachel R, Kettlety, Timothy R

Volltext

Validation of urinary HE4 as a biomarker for ovarian cancer von Li, Zhong-Qian, Fermer, Christian, Radwan, Rachel R., Hellman, Maria, He, Kuanglin, Falcone, Katherine L., Raju, Savitha S., Fegely, Maryellen, Vucetic, Zivjena, Dickson, Diana L., Kettlety, Timothy R., Moore, Richard G., Barnes, Grady

Volltext

Abstract 3574: Detection of serum CYFRA 21-1 as a biomarker for stratification of ovarian cancer risk in women with a pelvic mass von Li, Zhong-Qian, Smalley, Robert J., Glover, Curtis L., Radwan, Rachel R., Raju, Savitha, Falcone, Katherine L., Fegely, Maryellen, He, Kuanglin, Kettlety, Timothy R.

Volltext

Modulating multi-functional ERK complexes by covalent targeting of a recruitment site in vivo von Kaoud, Tamer S., Johnson, William H., Ebelt, Nancy D., Piserchio, Andrea, Zamora-Olivares, Diana, Van Ravenstein, Sabrina X., Pridgen, Jacey R., Edupuganti, Ramakrishna, Sammons, Rachel, Cano, Micael, Warthaka, Mangalika, Harger, Matthew, Tavares, Clint D. J., Park, Jihyun, Radwan, Mohamed F., Ren, Pengyu, Anslyn, Eric V., Tsai, Kenneth Y., Ghose, Ranajeet, Dalby, Kevin N.

Volltext

A comparison of levodopa treatment and task demands on visual evoked potentials in hemi-Parkinsonism von Mintz, Matti, Tomer, Rachel, Radwan, Henrik, Myslobodsky, Michael S.

Volltext